Submitted for Publication: February 6, 2014; final revision received March 7, 2014; accepted March 8, 2014.
Published Online: June 26, 2014. doi:10.1001/jamaophthalmol.2014.1422.
Study concept and design: Scott, Jackson, Quillen, Gardner.
Acquisition, analysis, or interpretation of data: Jackson, Quillen, Klein, Liao, Gardner.
Drafting of the manuscript: Scott, Liao, Gardner.
Critical revision of the manuscript for important intellectual content: Jackson, Quillen, Klein.
Statistical analysis: Jackson, Liao.
Obtained funding: Gardner.
Administrative, technical, or material support: Scott, Quillen.
Study supervision: Gardner.
Conflict of Interest Disclosures: Dr Jackson is an investor and employee of MacuLogix, Inc, the manufacturer of the AdaptDx device. No other disclosures were reported.
Funding/Support: This study was supported in part by grant 4-2007-231 from the Juvenile Diabetes Research Foundation (Dr Gardner), by a Research to Prevent Blindness Physician-Scientist Award (Dr Gardner), and by the Taubman Institute (Dr Gardner).
Role of the Sponsor: The funding sources had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.